DC-M: Conceptualization, Formal Analysis, Investigation, Writingoriginal draft, Writingreview and editing
Many users find that reducing to maintenance doses (2-4 mg weekly or even less frequent injections) sustains body composition improvements without the burden of higher doses
In addition, women in the treatment arm ( n = 85) were supplemented daily with 3 g of LC orally (day-3 until day of first positive pregnancy test), while those in the control arm (n = 85) received a placebo
By activating calcitonin receptors on pancreatic alpha cells, Cagrilintide reduces glucagon release, which in turn decreases hepatic glucose output and stabilizes blood glucose levels
[10] [11] This typically includes assessment of glycaemic control, cardiovascular risk factors, and treatment tolerability